Russell Frank Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CS
O
Russell Frank Company's XBI Position: Q1 2016 in Review
Russell Frank Company increased its State Street SPDR S&P Biotech ETF (XBI) stake by 21% in Q1 2016, buying an estimated $286K and bringing the position to 31,296 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1958.
Russell Frank Company first reported a position in XBI in Q3 2014 and has held it in 7 quarters since. The position peaked at $2.44M in Q2 2015. 195 funds tracked by Wall St. Rank hold XBI as of Q1 2016.
- Russell Frank Company held 31,296 shares of State Street SPDR S&P Biotech ETF worth $1.62M as of Q1 2016.
- Russell Frank Company bought 5,501 State Street SPDR S&P Biotech ETF shares in Q1 2016, an estimated $286K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #1958 holding.
- Russell Frank Company first reported a position in State Street SPDR S&P Biotech ETF in Q3 2014 and has held it in 7 quarters since.
- Russell Frank Company's State Street SPDR S&P Biotech ETF position peaked at $2.44M in Q2 2015.
- 195 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2016.
Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.